Prevalence of cardiovascular risk factors in patients with psoriasis

被引:796
作者
Neimann, Andrea L.
Shin, Daniel B.
Wang, Xingmei
Margolis, David J.
Troxel, Andrea B.
Gelfand, Joel M.
机构
[1] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.jaad.2006.08.040
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Previous studies suggest that patients hospitalized for psoriasis have an increased frequency of a variety of cardiovascular comorbidities. Limited population-based data exist on this association, and few studies have determined which factors are independently associated with psoriasis. Objective. We sought to determine whether the prevalence of the major cardiovascular risk factors was higher in mild and severe psoriasis than in patients without psoriasis. Methods: We conducted a population-based study in the United Kingdom using the General Practice Research Database. Patients were classified as having severe psoriasis if they received a code for psoriasis as well as systemic therapy. Patients were defined as having mild psoriasis if they ever received a psoriasis code but no systemic therapy. Control subjects were selected from the same practices and start dates as psoriasis patients. Patients were classified as having risk factors if they received codes for diabetes, hypertension, hyperlipidemia, obesity, or smoking. Analyses were performed by using conditional logistic regression, and adjustments were made considering age, gender, person-years, and all cardiovascular risk factors. Results: We identified 127,706 patients with mild psoriasis and 3854 with severe psoriasis. Respective prevalence rates of risk factors in those with severe psoriasis, mild psoriasis, and in controls were as follows: diabetes (7.1%, 4.4%, 3.3%), hypertension (20%, 14.7%, 11.9%), hyperlipidemia (6%, 4.7%, 3.3%), obesity (20.7%, 15.8%, 13.2%), and smoking (30.1%, 28%, 21.3%). Patients with mild psoriasis had a higher adjusted odds of diabetes (odds ratio [OR.], 1.13; 95% confidence interval [CI], 1.08-1.18]), hypertension (OR, 1.03; 95% CI, 1.01-1.06), hyperlipidemia (OR, 1.16; 95% CI, 1.12-1.21), obesity (OR, 1.27; 95% CI, 1.24-1.31), and smoking (OR, 1.31; 95% CI, 1.29-1.34) than controls. Patients with severe psoriasis had a higher adjusted odds of diabetes (OR, 1.62; 95% CL 1.3-2.01), obesity (OR, 1.79; 95% CI, 1.55-2.05), and smoking (OR, 1.31; 95% CI, 1.17-1.47) than controls. Additionally, diabetes (OR, 1.39; 95% Cl, 1.22-1.58) and obesity (OR, 1.47; 95% CI, 1.32-1.63) were more prevalent in those with severe psoriasis than with mild psoriasis. Limitations: The study was cross-sectional and therefore the directionality of the associations could not be determined. Conclusion: Multiple cardiovascular risk factors are associated with psoriasis. Cardiovascular risk factors that are key components of the metabolic syndrome are more strongly associated with severe psoriasis than with mild psoriasis.
引用
收藏
页码:829 / 835
页数:7
相关论文
共 44 条
  • [21] Psoriasis: epidemiology, clinical features, and quality of life
    Langley, RGB
    Krueger, GG
    Griffiths, CEM
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 18 - 23
  • [22] Agreement between GPRD smoking data: a survey of general practitioners and a Population-based survey
    Lewis, JD
    Brensinger, C
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2004, 13 (07) : 437 - 441
  • [23] MORTALITY AND CAUSES OF DEATH AMONG PSORIATICS
    LINDEGARD, B
    [J]. DERMATOLOGICA, 1989, 179 (02): : 91 - 92
  • [24] DISEASES ASSOCIATED WITH PSORIASIS IN A GENERAL-POPULATION OF 159,200 MIDDLE-AGED, URBAN, NATIVE SWEDES
    LINDEGARD, B
    [J]. DERMATOLOGICA, 1986, 172 (06): : 298 - 304
  • [25] Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
    Malik, S
    Wong, ND
    Franklin, SS
    Kamath, TV
    L'Italien, GJ
    Pio, JR
    Williams, GR
    [J]. CIRCULATION, 2004, 110 (10) : 1245 - 1250
  • [26] Psoriasis is associated with lipid abnormalities at the onset of skin disease
    Mallbris, L
    Granath, F
    Hamsten, A
    Ståhle, M
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 54 (04) : 614 - 621
  • [27] The effects of nicotine on the immune system
    McAllister-Sistilli, CG
    Caggiula, AR
    Knopf, S
    Rose, CA
    Miller, AL
    Donny, EC
    [J]. PSYCHONEUROENDOCRINOLOGY, 1998, 23 (02) : 175 - 187
  • [28] MCDONALD CJ, 1989, J INVEST DERMATOL, V92, P646, DOI 10.1111/1523-1747.ep12712210
  • [29] THROMBOEMBOLIC DISORDERS ASSOCIATED WITH PSORIASIS
    MCDONALD, CJ
    CALABRESI, P
    [J]. ARCHIVES OF DERMATOLOGY, 1973, 107 (06) : 918 - 918
  • [30] MCDONALD CJ, 1973, JAMA-J AM MED ASSOC, V224, P629